Factors Influencing the Use and Interpretation of Animal Models in the Development of Parenteral Drug Delivery Systems

被引:0
|
作者
Marilyn N. Martinez
机构
[1] US FDA/Center for Veterinary Medicine,
来源
The AAPS Journal | 2011年 / 13卷
关键词
animal model; interspecies differences; parenteral drug delivery; pharmacokinetics;
D O I
暂无
中图分类号
学科分类号
摘要
Depending upon the drug and drug delivery platform, species-specific physiological differences can lead to errors in the interspecies extrapolation of drug performance. This manuscript provides an overview of the species-specific physiological variables that can influence the performance of parenteral dosage forms such as in situ forming delivery systems, nanoparticles, microspheres, liposomes, targeted delivery systems, lipophilic solutions, and aqueous suspensions. Also discussed are those factors that can influence the partitioning of therapeutic compounds into tumors, the central nervous system and the lymphatics. Understanding interspecies differences in the movement and absorption of molecules is important to the interpretation of data generated through the use of animal models when studying parenteral drug delivery.
引用
收藏
页码:632 / 649
页数:17
相关论文
共 50 条
  • [1] Factors Influencing the Use and Interpretation of Animal Models in the Development of Parenteral Drug Delivery Systems
    Martinez, Marilyn N.
    AAPS JOURNAL, 2011, 13 (04): : 632 - 649
  • [2] NANOEMULSIONS AS PARENTERAL DRUG DELIVERY SYSTEMS
    Bruxel, Fernanda
    Laux, Manoela
    Wild, Luisa Bartmann
    Fraga, Michelle
    Koester, Leticia S.
    Teixeira, Helder F.
    QUIMICA NOVA, 2012, 35 (09): : 1827 - 1840
  • [3] Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems
    Winzenburg, G
    Schmidt, C
    Fuchs, S
    Kissel, T
    ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (10) : 1453 - 1466
  • [4] The Use of Animal Models for Cancer Chemoprevention Drug Development
    Steele, Vernon E.
    Lubet, Ronald A.
    SEMINARS IN ONCOLOGY, 2010, 37 (04) : 327 - 338
  • [5] THE USE OF PHARMACOKINETIC MODELS IN THE DEVELOPMENT AND EVALUATION OF SITE-SPECIFIC DRUG DELIVERY SYSTEMS
    AARONS, L
    BODDY, A
    PESTICIDE SCIENCE, 1990, 30 (01): : 91 - 95
  • [6] Animal models for transdermal drug delivery
    Panchagnula, R
    Stemmer, K
    Ritschel, WA
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1997, 19 (05): : 335 - 341
  • [7] THE USE OF ANIMAL-MODELS IN CANCER DRUG DISCOVERY AND DEVELOPMENT
    CURT, GA
    STEM CELLS, 1994, 12 (01) : 23 - 29
  • [8] General factors influencing drug delivery to the lung
    Ganderton, D
    RESPIRATORY MEDICINE, 1997, 91 : 13 - 16
  • [9] In situ forming parenteral drug delivery systems: an overview
    Packhaeuser, CB
    Schnieders, J
    Oster, CG
    Kissel, T
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) : 445 - 455
  • [10] Nanoparticles for cellular drug delivery: Mechanisms and factors influencing delivery
    Chavanpatil, Mahesh D.
    Khdair, Ayman
    Panyam, Jayanth
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2006, 6 (9-10) : 2651 - 2663